Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK7653 monotherapy in type 2 diabetes mellitus
CTR20201759Phase 3Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cofrogliptin in type 2 diabetes mellitus (T2DM), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd.. Started Aug 2020; status: completed.
02
Drugs
cofrogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20201759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201759.